Johnson & Johnson's vaccine news proves it's vital to read articles and not just headlines

As a writer, few things grate my nerves like people reacting to a headline without actually reading the article, and yet it happens all the time. I've had people try to defend this practice ("It's your fault for writing the headline that way!") but no matter how it's written, a headline is never going to be a full story. Never ever. An article's worth of information cannot be encapsulated in 90-characters-or-less, and distilling the essence of a piece in a way that is both informative and inspires people to read it is more complicated than it looks.

On that note, let's talk about the Johnson and Johnson vaccine news that came out today, because people who don't read beyond the headlines are getting a skewed picture of the efficacy of this vaccine. Here are some samples of the wording major news organizations used in their headlines and social media share texts this morning:

"Covid vaccine: Single dose Covid vaccine 66% effective"BBC

"Johnson & Johnson COVID-19 vaccine 66% effective in global trial, company says" Fox News

"Johnson & Johnson COVID-19 vaccine is 72% effective in the U.S., and 66% overall in large trial"Reuters

"Johnson & Johnson's single-dose Covid-19 vaccine was 66 percent effective at preventing moderate and severe disease in a global study"Politico

"Johnson & Johnson vaccine is 66% effective in preventing moderate to severe COVID-19, a global study finds" NPR

"Single-shot Johnson & Johnson vaccine 66% effective against moderate to severe covid-19, but worked less well in variant hot spot"Washington Post

I shudder to think of how many people are going to glance through the news, see headlines like this, and say to themselves "Oh, I guess the J & J vaccine basically sucks compared to the 95% effective mRNA ones." And I lament how many will not have the far more appropriate reaction of, "Wow, the J & J vaccine is 100% effective at preventing hospitalizations and death from COVID! How amazing!"

That's right. Zero hospitalizations and zero deaths in the 44,000 person trial—a hugely significant detail you'd miss if you only read those "66% effective" headlines. The vaccine is also 85% effective at preventing severe illness (presumably meaning bad symptoms but not quite bad enough to need hospitalization) 28 days after the shot, and 100% at preventing severe illness 49 days after. How is that not incredible news?





To read the 66% headlines—and even some full articles, surprisingly—you'd never know how effective this vaccine actually is in the ways that count the most. You might even assume that statistic means that 34% of people still have a chance of getting COVID and dying after getting this vaccine, when that's not the case at all.

The primary goal of COVID immunization is to keep people from dying and/or getting severely ill from the virus so we can return to normalcy as soon as possible. This vaccine does that. That's the detail that should be dominating the headlines. Of course, we'd love to see a vaccine that prevents all sickness, but that's a tall order for any inoculation. Even the 66% efficacy is good for a new vaccine, and if anything, it just goes to show how incredibly effective the mRNA versions are. But the bottom line is this is a life-saving vaccine, full stop.

That doesn't mean it's perfect or just as effective as the mRNA vaccines from Pfizer and Moderna. There are still questions about whether or not these vaccines can prevent people from carrying the virus, and there are some concerns about decreases in vaccine effectiveness on some of the variants we're seeing pop up around the world.

But there's a reason epidemiologists are still referring to this vaccine as a "game-changer."




One key feature of the Johnson & Johnson vaccine is that it only requires a single dose. Considering the logistical and cost challenges of getting people to show up for two shots several weeks apart, that's a big deal. The vaccine also only requires refrigeration to be shipped and stored—unlike the Pfizer vaccine, which has to be kept at minus 70 degrees celsius—which opens up the door to getting far more people vaccinated far more quickly in far more places around the globe. In a pandemic like this one, those details do indeed change the game.

A repeated lament I've seen from many public health officials is that so much news coverage and messaging on COVID vaccines downplays how amazing it is that we even have them at this point, much less how effective they are. For a novel virus, vaccine development has gone incredibly well, and it is a testament to modern science and that we have several effective vaccines less than a year into a pandemic.

All of this is fabulous pandemic news, but you'd never know it if you only read the headlines.



The moral of this story is please, please, please always read articles in full before reacting. As much as I wish news outlets had avoided choosing to highlight the "66% effective" stat over the "100% hospitalization and death prevention" stat, I also know that there's no perfect way to write a headline. We're all bombarded by news and links, but people have to get over the habit of assuming a headline has all of the info, or even the most important info, and get in the habit of clicking and reading.

And if you've made it to this line, thank you for being part of the solution and not part of the problem. High five.

Courtesy of Creative Commons
True

After years of service as a military nurse in the naval Marine Corps, Los Angeles, California-resident Rhonda Jackson became one of the 37,000 retired veterans in the U.S. who are currently experiencing homelessness — roughly eight percent of the entire homeless population.

"I was living in a one-bedroom apartment with no heat for two years," Jackson said. "The Department of Veterans Affairs was doing everything they could to help but I was not in a good situation."

One day in 2019, Jackson felt a sudden sense of hope for a better living arrangement when she caught wind of the ongoing construction of Veteran's Village in Carson, California — a 51-unit affordable housing development with one, two and three-bedroom apartments and supportive services to residents through a partnership with U.S.VETS.

Her feelings of hope quickly blossomed into a vision for her future when she learned that Veteran's Village was taking applications for residents to move in later that year after construction was complete.

"I was entered into a lottery and I just said to myself, 'Okay, this is going to work out,'" Jackson said. "The next thing I knew, I had won the lottery — in more ways than one."

Keep Reading Show less
via Ken Lund / Flickr

The dark mountains that overlook Provo, Utah were illuminated by a beautiful rainbow-colored "Y" on Thursday night just before 8 pm. The 380-foot-tall "Y" overlooks the campus of Brigham Young University, a private college owned by the Utah-based Church of Jesus Christ of Latter-day Saints (LDS Church), commonly known as Mormons.

The display was planned by a group of around 40 LGBT students to mark the one-year anniversary of the university sending out a letter clarifying its stance on homosexual behavior.

"One change to the Honor Code language that has raised questions was the removal of a section on 'Homosexual Behavior.' The moral standards of the Church did not change with the recent release of the General Handbook or the updated Honor Code, " the school's statement read.

Keep Reading Show less
True

We're redefining what normal means in these uncertain times, and although this is different for all of us, love continues to transform us for the better.

Love is what united Marie-Claire and David Archbold, who met while taking a photography class. "We went into the darkroom to see what developed," they joke—and after a decade of marriage, they know firsthand the deep commitment and connection romantic love requires.

All photos courtesy of Marie-Claire and David Archbold

However, their relationship became even sweeter when they adopted James: a little boy with a huge heart.

In the United States alone, there are roughly 122,000 children awaiting adoption according to the latest report from the U.S Department of Health and Human Services. While the goal is always for a child to be parented by and stay with their biological family, that is not always a possibility. This is where adoption offers hope—not only does it create new families, it gives birth parents an avenue through which to see their child flourish when they are not able to parent. For the right families, it's a beautiful thing.

The Archbolds knew early on that adoption was an option for them. David has three daughters from a previous marriage, but knowing their family was not yet complete, the couple embarked on a two-year journey to find their match. When the adoption agency called and told them about James, they were elated. From the moment they met him, the Archbolds knew he was meant to be part of their family. David locked eyes with the brown-eyed baby and they stared at each other in quiet wonder for such a long time that the whole room fell silent. "He still looks at me like that," said David.

The connection was mutual and instantaneous—love at first sight. The Archbolds knew that James was meant to be a part of their family. However, they faced significant challenges requiring an even deeper level of commitment due to James' medical condition.

James was born with congenital hyperinsulinism, a rare condition that causes his body to overproduce insulin, and within 2 months of his birth, he had to have surgery to remove 90% of his pancreas. There was a steep learning curve for the Archbolds, but they were already in love, and knew they were committed to the ongoing care that'd be required of bringing James into their lives. After lots of research and encouragement from James' medical team, they finally brought their son home.

Today, three-year-old James is thriving, filled with infectious joy that bubbles over and touches every person who comes in contact with him. "Part of love is when people recognize that they need to be with each other," said his adoptive grandfather. And because the Archbolds opted for an open adoption, there are even more people to love and support James as he grows.

This sweet story is brought to you by Sumo Citrus®. This oversized mandarin is celebrated for its incredible taste and distinct looks. Sumo Citrus is super-sweet, enormous, easy-to-peel, seedless, and juicy without the mess. Fans of the fruit are obsessive, stocking up from January to April when Sumo Citrus is in stores. To learn more, visit sumocitrus.com and @sumocitrus.

You know that feeling you get when you walk into a classroom and see someone else's stuff on your desk?

OK, sure, there are no assigned seats, but you've been sitting at the same desk since the first day and everyone knows it.

So why does the guy who sits next to you put his phone, his book, his charger, his lunch, and his laptop in the space that's rightfully yours? It's annoying!

Keep Reading Show less
Public Domain

A very simple thing happened earlier this week. Dr. Seuss Enterprises—the company that runs the Dr. Seuss estate and holds the legal rights to his works—announced it will no longer publish six Dr. Seuss children's books because they contain depictions of people that are "hurtful and wrong" (their words). The titles that will no longer be published are And to Think That I Saw It on Mulberry Street, If I Ran the Zoo, McElligot's Pool, On Beyond Zebra!, Scrambled Eggs Super! and The Cat's Quizzer.

This simple action prompted a great deal of debate, along with a great deal of disinformation, as people reacted to the story. (Or in many cases, just the headline. It's a thing.)

My article about the announcement (which contains examples of the problematic content that prompted the announcement) led to nearly 3,000 comments on Upworthy's Facebook page. Since many similar comments were made repeatedly, I wanted to address the most common sentiments and questions:

How do we learn from history if we keep erasing it?

Keep Reading Show less